SEC Form SC 13G filed by Embecta Corp.

1/30/24 12:44:13 PM ET

Medical/Dental Instruments

Health Care

Get the next $EMBC alert in real time by email

SC 13G 1 embc.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Embecta Corp. ------------------------------------ (Name of Issuer) Common Stock ------------------------------------ (Title of Class of Securities) 29082K105 -------------------- (CUSIP Number) December 31, 2023 ------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). PAGE 1 OF 4 PAGES -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON River Road Asset Management, LLC 43-2076925 -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] N/A -------------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 3,171,702 NUMBER OF ----------------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY OWNED BY 0 EACH ----------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON WITH 3,310,749 ----------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,310,749 -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* N/A -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.8% -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IA -------------------------------------------------------------------------------- PAGE 2 OF 4 PAGES Item 1(a) Name of Issuer: Embecta Corp. Item 1(b) Address of Issuer's Principal Executive Offices: 300 Kimball Drive, Suite 300 Parsippany, NJ 07054 Item 2(a) Name of Person Filing: River Road Asset Management, LLC Item 2(b) Address of the Principal Office or, if none, Residence: 462 S. 4th St., Ste 2000 Louisville, KY 40202 Item 2(c) Citizenship: US -- State of Delaware Item 2(d) Title of Class of Securities: Common Stock Item 2(e) CUSIP Number: 29082K105 Item 3 If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (e) [X] An investment advisor in accordance with section 240.13d-1(b)(1)(ii)(E) Item 4 Ownership: (a) Amount Beneficially Owned: 3,310,749 (b) Percent of Class: 5.8% PAGE 3 OF 4 PAGES (c) Number of shares as to which such person has: (i) sole power to vote or direct the vote: 3,171,702 (ii) shared power to vote or direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 3,310,749 (iv) shared power to dispose or to direct the disposition of: 0 Item 5 Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6 Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable. Item 8 Identification and Classification of Members of the Group: Not applicable. Item 9 Notice of Dissolution of a Group: Not applicable. Item 10 Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 30, 2024 River Road Asset Management, LLC By: /S/ THOMAS DIGNAN MUELLER ------------------------------------- Name: Thomas Dignan Mueller Title: CCO/COO PAGE 4 OF 4 PAGES

Get the next $EMBC alert in real time by email

Recent Analyst Ratings for

$EMBC

Date	Price Target	Rating	Analyst
4/10/2025	$15.00	Neutral	Mizuho
12/2/2024	$13.00 → $20.00	Underweight → Equal-Weight	Morgan Stanley
11/27/2024	$26.00	Neutral → Buy	BTIG Research
10/20/2023		Peer Perform	Wolfe Research
1/6/2023	$28.00	Equal-Weight → Underweight	Morgan Stanley
9/8/2022		Neutral	BTIG Research
8/1/2022	$33.00	Equal-Weight	Morgan Stanley
6/21/2022	$25.00	Underperform	BofA Securities

More analyst ratings

SEC Form SC 13G filed by Embecta Corp.

Chat with this insight

Recent Analyst Ratings for $EMBC

$EMBC Press Releases

Fastest customizable press release news feed in the world

embecta to Participate in Investor Events

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

$EMBC Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Embecta Corp.

Amendment: SEC Form SC 13G/A filed by Embecta Corp.

SEC Form SC 13G filed by Embecta Corp.

$EMBC Financials

Live finance-specific insights

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Report Fiscal Second Quarter 2025 Financial Results

$EMBC Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

SVP and CFO Elguicze Jacob covered exercise/tax liability with 4,948 shares, decreasing direct ownership by 3% to 168,599 units (SEC Form 4)

SVP, Global Manuf./Sup. Chain Curtis Shaun covered exercise/tax liability with 3,249 shares, decreasing direct ownership by 5% to 59,061 units (SEC Form 4)

$EMBC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

Melcher David F bought $32,500 worth of shares (2,000 units at $16.25), increasing direct ownership by 5% to 45,080 units (SEC Form 4)

$EMBC Leadership Updates

Live Leadership Updates

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors

$EMBC SEC Filings

SEC Form SD filed by Embecta Corp.

Embecta Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by Embecta Corp.

$EMBC Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Mizuho initiated coverage on Embecta Corp. with a new price target

Embecta Corp. upgraded by Morgan Stanley with a new price target

Embecta Corp. upgraded by BTIG Research with a new price target

Recent Analyst Ratings for
$EMBC

$EMBC
Press Releases

$EMBC
Large Ownership Changes

$EMBC
Financials

$EMBC
Insider Trading

$EMBC
Insider Purchases

$EMBC
Leadership Updates

$EMBC
SEC Filings

$EMBC
Analyst Ratings